Biomarkers for Liquid Biopsies of Pituitary Neuroendocrine Tumors
Pituitary neuroendocrine tumors (PitNET) do not only belong to the most common intracranial neoplasms but seem to be generally more common than has been thought. Minimally invasive liquid biopsies have the potential to improve their early screening efficiency as well as monitor prognosis by facilita...
Main Authors: | Wilhelm Gossing, Marcus Frohme, Lars Radke |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2020-06-01
|
Series: | Biomedicines |
Subjects: | |
Online Access: | https://www.mdpi.com/2227-9059/8/6/148 |
Similar Items
-
Cell-Free RNA as a Novel Biomarker for Response to Therapy in Head & Neck Cancer
by: Anela Tosevska, et al.
Published: (2022-05-01) -
Promises and Challenges of Predictive Blood Biomarkers for Locally Advanced Rectal Cancer Treated with Neoadjuvant Chemoradiotherapy
by: Joao Victor Machado Carvalho, et al.
Published: (2023-01-01) -
Liquid Biopsies in Lung Cancer
by: Marcel Kemper, et al.
Published: (2023-02-01) -
Liquid biopsy for therapy monitoring in early-stage non-small cell lung cancer
by: Misako Nagasaka, et al.
Published: (2021-06-01) -
Circulating cell‐free messenger RNA enables non‐invasive pan‐tumour monitoring of melanoma therapy independent of the mutational genotype
by: Lea Jessica Albrecht, et al.
Published: (2022-11-01)